Cargando…

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours

Activation of the ERK1/2 pathway is involved in malignant transformation both in vitro and in vivo. Little is known about the role of activated ERK1/2 in non-small cell lung cancer (NSCLC). The purpose of this study was to characterise the extent of the activation of ERK1/2 by immunohistochemistry i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vicent, S, López-Picazo, J M, Toledo, G, Lozano, M D, Torre, W, Garcia-Corchón, C, Quero, C, Soria, J-C, Martín-Algarra, S, Manzano, R G, Montuenga, L M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409626/ https://www.ncbi.nlm.nih.gov/pubmed/14997206 http://dx.doi.org/10.1038/sj.bjc.6601644

Ejemplares similares

Intra-tumoural microvessel density in human solid tumours
por: Hasan, J, et al.
Publicado: (2002)

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
por: Lantuejoul, S, et al.
Publicado: (2004)

The embedded tumour: host physiology is important for the evaluation of tumour growth
por: van Leeuwen, I M M, et al.
Publicado: (2003)

The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
por: Masuya, D, et al.
Publicado: (2004)

Heterogeneity of O(6)-alkylguanine DNA-alkyltransferase expression in human breast tumours
por: Clemons, M J, et al.
Publicado: (2002)

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
por: Koukourakis, M I, et al.
Publicado: (2003)

RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma
por: Shyu, R-Y, et al.
Publicado: (2003)

Prognostic impact of chromosomal aberrations in Ewing tumours
por: Hattinger, C M, et al.
Publicado: (2002)

Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer
por: Mamot, C, et al.
Publicado: (2003)

Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers
por: Lee, K T, et al.
Publicado: (2004)

A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer
por: Van Trappen, P O, et al.
Publicado: (2002)

Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness
por: Blot, E, et al.
Publicado: (2003)

Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004)

Increased aquaporin 1 water channel expression inhuman brain tumours
por: Saadoun, S, et al.
Publicado: (2002)

Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment
por: Baeten, C I M, et al.
Publicado: (2002)

Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH)
por: Fiegl, M, et al.
Publicado: (2004)

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
por: Yousef, G M, et al.
Publicado: (2002)

p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer
por: Fondevila, C, et al.
Publicado: (2004)

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
por: Kim, M, et al.
Publicado: (2003)

Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres
por: Gisselsson, D, et al.
Publicado: (2002)

Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications
por: Ferrandina, G, et al.
Publicado: (2002)

Potential use of the alkaline comet assay as a predictor of bladder tumour response to radiation
por: McKeown, S R, et al.
Publicado: (2003)

Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours
por: Sotiropoulou, P A, et al.
Publicado: (2003)

Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development
por: Zuidervaart, W, et al.
Publicado: (2003)

Tumour-derived TGF-β1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells
por: Lewis, M P, et al.
Publicado: (2004)

Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas
por: Passalidou, E, et al.
Publicado: (2002)

DNA topoisomerase I and II expression in drug resistantgerm cell tumours
por: Berney, D M, et al.
Publicado: (2002)

Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours
por: Zurita, A J, et al.
Publicado: (2003)

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients
por: Ady, N, et al.
Publicado: (2004)

Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage
por: Pardo, F S, et al.
Publicado: (2004)

Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status
por: Perel, Y, et al.
Publicado: (2002)

Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas
por: Yan, Y, et al.
Publicado: (2004)

Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression
por: Krieg, A, et al.
Publicado: (2002)

Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer
por: Anderson, T J, et al.
Publicado: (2002)

ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
por: Grützmann, R, et al.
Publicado: (2004)

An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation
por: Cascinu, S, et al.
Publicado: (2002)

S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas
por: Smith, S L, et al.
Publicado: (2004)

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
por: Santin, A D, et al.
Publicado: (2004)

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
por: Tynninen, O, et al.
Publicado: (2002)

The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system
por: Burns, A S Y W, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_mjeecl5uaserbu5oe8i7s3ko2t